These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 510387)

  • 21. Dopamine receptor binding regulated by guanine nucleotides.
    Creese I; Usdin TB; Snyder SH
    Mol Pharmacol; 1979 Jul; 16(1):69-76. PubMed ID: 481426
    [No Abstract]   [Full Text] [Related]  

  • 22. Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems.
    Robertson HA
    Brain Res; 1983 May; 267(1):179-82. PubMed ID: 6860944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of a conformationally restricted dopamine analogue, 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, to receptors on rat brain synaptic membranes.
    Roberts PJ; Woodruff GN; Poat JA
    Mol Pharmacol; 1977 May; 13(3):541-7. PubMed ID: 17829
    [No Abstract]   [Full Text] [Related]  

  • 24. Selective reduction of one class of dopamine receptor binding sites in the corpus striatum of aged rats.
    De Blasi A; Mennini T
    Brain Res; 1982 Jun; 242(2):361-4. PubMed ID: 7116143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The uptake and release of [3-H]-2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthlane (ADTN) by striatal nerve terminals.
    Davis A; Roberts PJ; Woodruff GN
    Br J Pharmacol; 1978 May; 63(1):183-90. PubMed ID: 647158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina.
    Makman MH; Dvorkin B; Klein PN
    Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4212-6. PubMed ID: 6213964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
    Makman MH; Dvorkin B; Horowitz SG; Thal LJ
    Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The localization of receptor binding sites in the substantia nigra and striatum of the rat.
    Reisine TD; Nagy JI; Beaumont K; Fibiger HC; Yamamura HI
    Brain Res; 1979 Nov; 177(2):241-52. PubMed ID: 227532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Striatal glutamatergic function: modifications following specific lesions.
    Roberts PJ; McBean GJ; Sharif NA; Thomas EM
    Brain Res; 1982 Mar; 235(1):83-91. PubMed ID: 6145487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for differential localization of angiotensin-I converting enzyme and renin in the corpus striatum of rat.
    Fuxe K; Ganten D; Köhler C; Schüll B; Speck G
    Acta Physiol Scand; 1980 Nov; 110(3):321-3. PubMed ID: 6259884
    [No Abstract]   [Full Text] [Related]  

  • 31. Enkephalin receptors on dopaminergic neurones in rat striatum.
    Pollard H; Llorens-Cortes C; Schwartz JC
    Nature; 1977 Aug; 268(5622):745-7. PubMed ID: 197427
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) as a ligand for brain dopamine receptors [proceedings].
    Cross AJ; Crow TJ; Owen F
    Br J Pharmacol; 1979 May; 66(1):87P. PubMed ID: 454971
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of R(+)-ADTN in dopamine receptor binding assays.
    Davis A; Poat JA; Woodruff GN
    Eur J Pharmacol; 1980 May; 63(2-3):237-8. PubMed ID: 6155278
    [No Abstract]   [Full Text] [Related]  

  • 34. Preferential activation of [3H]phorbol-12,13-dibutyrate binding by AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) in neonatal striatal cell cultures.
    McMillian M; Hong JS; Pennypacker KR
    Brain Res; 1992 Oct; 593(2):307-10. PubMed ID: 1280525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum.
    Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
    Eur J Pharmacol; 1979 Oct; 58(3):341-2. PubMed ID: 510367
    [No Abstract]   [Full Text] [Related]  

  • 36. Binding characteristics of the dopamine uptake inhibitor [3H]nomifensine to striatal membranes.
    Dubocovich ML; Zahniser NR
    Biochem Pharmacol; 1985 Apr; 34(8):1137-44. PubMed ID: 3158318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat.
    Rebola N; Canas PM; Oliveira CR; Cunha RA
    Neuroscience; 2005; 132(4):893-903. PubMed ID: 15857695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of [3H]apomorphine to striatal membranes prepared from rat brain after 6-hydroxydopamine and kainic acid lesions.
    Fujita N; Saito K; Iwatsubo K; Hirata A; Noguchi Y; Yoshida H
    Brain Res; 1980 May; 190(2):593-6. PubMed ID: 7370810
    [No Abstract]   [Full Text] [Related]  

  • 39. Analysis of dopamine interactions with [3H]-spiperone binding sites on rat corpus striatum membranes [proceedings].
    Howlett DR; Nahorski SR
    Br J Pharmacol; 1979 Jul; 66(3):468P-469P. PubMed ID: 526752
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of chronic treatment with l-sulpiride and haloperidol on central monoaminergic mechanisms.
    Fuxe K; Ogren SO; Hall H; Agnati LF; Andersson K; Köhler C; Schwarcz R
    Adv Biochem Psychopharmacol; 1980; 24():193-206. PubMed ID: 6967676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.